200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 17812-07-6

17812-07-6

17812-07-6 | 2-Butenoic acid, 4-oxo-4-phenyl-, (2E)-

CAS No: 17812-07-6 Catalog No: AG0025RR MDL No:MFCD00014015

Product Description

Catalog Number:
AG0025RR
Chemical Name:
2-Butenoic acid, 4-oxo-4-phenyl-, (2E)-
CAS Number:
17812-07-6
Molecular Formula:
C10H8O3
Molecular Weight:
176.1687
MDL Number:
MFCD00014015
IUPAC Name:
(E)-4-oxo-4-phenylbut-2-enoic acid
InChI:
InChI=1S/C10H8O3/c11-9(6-7-10(12)13)8-4-2-1-3-5-8/h1-7H,(H,12,13)/b7-6+
InChI Key:
PLPDHGOODMBBGN-VOTSOKGWSA-N
SMILES:
O=C(c1ccccc1)/C=C/C(=O)O
NSC Number:
143

Properties

Complexity:
224  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
176.047g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
176.171g/mol
Monoisotopic Mass:
176.047g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
54.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  

Literature

Title Journal
Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay. ACS chemical biology 20120316
Antiproliferative activity of aroylacrylic acids. Structure-activity study based on molecular interaction fields. European journal of medicinal chemistry 20110801
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors. Journal of medicinal chemistry 20030327
UV filter instability: consequences for the human lens. Experimental eye research 20020801
Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrobial agents and chemotherapy 19941201

© 2019 Angene International Limited. All rights Reserved.